Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records.
- DOI
- 10.1007/s10549-024-07506-4
- Published
- 2025 Jan
- Container
- Breast cancer research and treatment
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s10549-024-07506-4,
title = {Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records.},
author = {Cottu P and Cheeseman S and Hall P and Wöckel A and Scholz CW and Bria E and Orlandi A and Ribelles N and Vallet M and Niklas N and Hogg C and Aggarwal S and Moreira J and Lucerna M and Collin SM and Logue A and Long GH},
year = {2025},
journal = {Breast cancer research and treatment},
doi = {10.1007/s10549-024-07506-4},
url = {https://doi.org/10.1007/s10549-024-07506-4}
}RIS
TY - JOUR TI - Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records. AU - Cottu P AU - Cheeseman S AU - Hall P AU - Wöckel A AU - Scholz CW AU - Bria E AU - Orlandi A AU - Ribelles N AU - Vallet M AU - Niklas N AU - Hogg C AU - Aggarwal S AU - Moreira J AU - Lucerna M AU - Collin SM AU - Logue A AU - Long GH PY - 2025 JO - Breast cancer research and treatment DO - 10.1007/s10549-024-07506-4 UR - https://doi.org/10.1007/s10549-024-07506-4 ER -
APA
P, C., S, C., P, H., A, W., CW, S., E, B., A, O., N, R., M, V., N, N., C, H., S, A., J, M., M, L., SM, C., A, L., & GH, L. (2025). Attrition between lines of therapy and real-world outcomes of patients with HER2-positive metastatic breast cancer in Europe: a cohort study leveraging electronic medical records.. Breast cancer research and treatment. https://doi.org/10.1007/s10549-024-07506-4
Source records
- pubmed · retrieved 2026-09-26T15:12:20.046Z